Central sleep apnea: pathophysiologic classification
Sleep · 09.03.2023 · 46 (3)
DOI: 10.1093/sleep/zsac113 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sleep, online erschienen am 11.05.2022. Verfasst von Shahrokh Javaheri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Bethesda North Hospital, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Central, Heart Failure. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Central sleep apnea is not a single disorder; it can present as an isolated disorder or as a part of other clinical syndromes. In some conditions, such as heart failure, central apneic events are due to transient inhibition of ventilatory motor output during sleep, owing to the overlapping influences of sleep and hypocapnia. Specifically, the sleep state is associated with removal of wakefulness drive to breathe; thus, rendering ventilatory motor output dependent on the metabolic ventilatory control system, principally PaCO2. Accordingly, central apnea occurs when PaCO2 is reduced below the “apneic threshold”. Our understanding of the pathophysiology of central sleep apnea has evolved appreciably over the past decade; accordingly, in disorders such as heart failure, central apnea is viewed as a form of breathing instability, manifesting as recurrent cycles of apnea/hypopnea, alternating with hyperpnea. In other words, ventilatory control operates as a negative—feedback closed-loop system to maintain homeostasis of blood gas tensions within a relatively narrow physiologic range, principally PaCO2. Therefore, many authors have adopted the engineering concept of “loop gain” (LG) as a measure of ventilatory instability and susceptibility to central apnea. Increased LG promotes breathing instabilities in a number of medical disorders. In some other conditions, such as with use of opioids, central apnea occurs due to inhibition of rhythm generation within the brainstem. This review will address the pathogenesis, pathophysiologic classification, and the multitude of clinical conditions that are associated with central apnea, and highlight areas of uncertainty.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Sleep Medicine, Bethesda North Hospital, Cincinnati, OH, USA.
- Division of Pulmonary Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH, USA.
- Division of Cardiology, Department of Medicine, Ohio State University, Columbus, OH, USA.
- Department of Internal Medicine, Liborio Tranchida, MD, Endowed Professor of Medicine, Wayne State University School of Medicine, University Health Center, Detroit, MI, USA.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Javaheri, S., & Badr, M. S. (2023). Central sleep apnea: pathophysiologic classification. Sleep, 46(3). https://doi.org/10.1093/sleep/zsac113
Vancouver
Javaheri S, Badr MS. Central sleep apnea: pathophysiologic classification. Sleep. 2023;46(3). doi:10.1093/sleep/zsac113
BibTeX
@article{Javaheri2023,
author = {Javaheri, Shahrokh and Badr, M Safwan},
title = {Central sleep apnea: pathophysiologic classification},
journal = {Sleep},
year = {2023},
volume = {46},
number = {3},
doi = {10.1093/sleep/zsac113}
}
EUVIMED